Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
Andreas Wollenberg, Stéphanie Christen-Zäch, Alain Taı̈eb, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 12, pp. 2717-2744
Open Access | Times Cited: 361

Showing 1-25 of 361 citing articles:

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Thomas Bieber
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 1, pp. 21-40
Open Access | Times Cited: 420
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
Andreas Wollenberg, Maria Kinberger, B.W.M. Arents, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 9, pp. 1409-1431
Open Access | Times Cited: 251
Update on the Pathogenesis and Therapy of Atopic Dermatitis
Huaguo Li, Zhen Zhang, Hui Zhang, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 324-338
Closed Access | Times Cited: 172
European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations
Andreas Wollenberg, Maria Kinberger, B.W.M. Arents, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 11, pp. 1904-1926
Open Access | Times Cited: 162
Pathogenesis of allergic diseases and implications for therapeutic interventions
Ji Wang, Yumei Zhou, Honglei Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 143
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 447-461
Open Access | Times Cited: 31
Skin as the target for allergy prevention and treatment
Andreina Marques‐Mejias, Irene Bartha, Christina E. Ciaccio, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 2, pp. 133-143
Open Access | Times Cited: 19
Recent Advancements in the Atopic Dermatitis Mechanism
Maria Savva, Nikolaos G. Papadopoulos, Stamatios Gregoriou, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 17
Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Skin microbiota: pathogenic roles and implications in atopic dermatitis
Cong Huang, Fan Zhuo, Yang Guo, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 2
Nomenclature and clinical phenotypes of atopic dermatitis
Giampiero Girolomoni, Marjolein de Bruin‐Weller, Valéria Aoki, et al.
Therapeutic Advances in Chronic Disease (2021) Vol. 12
Open Access | Times Cited: 83
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders
Jonathan I. Silverberg, Eric L. Simpson, Andreas Wollenberg, et al.
JAMA Dermatology (2021) Vol. 157, Iss. 6, pp. 691-691
Open Access | Times Cited: 73
Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo‐controlled, randomized, phase III clinical trial (ECZTRA 7)*
Jan Gutermuth, Andrew Pink, Margitta Worm, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 3, pp. 440-452
Open Access | Times Cited: 68
Urea in Dermatology: A Review of its Emollient, Moisturizing, Keratolytic, Skin Barrier Enhancing and Antimicrobial Properties
Jaime Piquero‐Casals, D. Morgado‐Carrasco, Corinne Granger, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 6, pp. 1905-1915
Open Access | Times Cited: 67
Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials
Andreas Wollenberg, Lisa A. Beck, Marjolein de Bruin‐Weller, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 3, pp. 453-465
Open Access | Times Cited: 64
Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options
Thomas Bieber, Amy S. Paller, Kenji Kabashima, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 9, pp. 1432-1449
Open Access | Times Cited: 58
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
Andrew Blauvelt, Richard Langley, J.‐P. Lacour, et al.
Journal of the American Academy of Dermatology (2022) Vol. 87, Iss. 4, pp. 815-824
Open Access | Times Cited: 52
Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
Kim Papp, Jacek C. Szepietowski, Leon Kircik, et al.
Journal of the American Academy of Dermatology (2022) Vol. 88, Iss. 5, pp. 1008-1016
Closed Access | Times Cited: 52
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
Eric L. Simpson, Joseph F. Merola, Jonathan I. Silverberg, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 6, pp. 888-899
Open Access | Times Cited: 49
Atopic Dermatitis and Food Allergy: A Complex Interplay What We Know and What We Would Like to Learn
Niki Papapostolou, Paraskevi Xepapadaki, Stamatios Gregoriou, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 4232-4232
Open Access | Times Cited: 43
Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis
Simon G. Danby, Paul V. Andrew, Rosie Taylor, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 6, pp. 1154-1164
Open Access | Times Cited: 41
Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis
Natalia Alkon, Frank P. Assen, T. Arnoldner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 2, pp. 420-435
Closed Access | Times Cited: 35
Atopic dermatitis in children and adults
Andreas Wollenberg, Thomas Werfel, Johannes Ring, et al.
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 30
Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review
Anne‐Laure Demessant‐Flavigny, Sophie Connétable, Delphine Kérob, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. S5, pp. 3-17
Open Access | Times Cited: 30
Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice
Anne R. Schlösser, Madena Shareef, Jill I. Olydam, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 5, pp. 510-517
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top